RxDoctor Payments Data

Ryan Frank

Podiatrist · Independence, MONPI 1528062130

Payments from drug & device makers

What this record shows

This record is dominated by other: $12,150 of the $14,567 with a category attached, or 83.4%. Acera Surgical, Inc. accounts for 84.2% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2022 at $12,643 and has fallen 98.8% since, to $157 in 2025. Among podiatrist clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,567in general payments, 2019–2025

Across 101 payments — averaging $144.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acera Surgical, Inc.$12K
  • Organogenesis Inc.$705
  • AbbVie$278
  • Kerecis Limited$255
  • Nevro Corp.$140
  • Melinta Therapeutics, LLC$106
  • plus $815 from 24 others

What the payments were for

  • Speaking & faculty fees$1111%
  • Food & beverage$2,30616%
  • Other$12,15083%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,567 in reported general payments places this provider in the 95th percentile of 105 podiatrist providers in Missouri.

See all podiatrist providers in Missouri

Medicare billing

Part B allowed, 2024
$131,632
Medicare patients
666
Services billed
2,183

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox16$445
Doxycycline Hyclate24$254
Terbinafine Hcl11$185
Gabapentin15$146
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav22$144
Levofloxacin13$37

Paid to pharmacies, not to this prescriber.

Other podiatrist in Independence

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →